Inhibition of HepG2 cell proliferation by ursolic acid and polysaccharides via the downregulation of cyclooxygenase-2

Liu,Ling; Zhang,Jingkai; Li,Meiling; Zhang,Xiaohong; Zhang,Jinlu; Li,Zhenjing; Wang,Likui; Wu,Jihui; Luo,Cheng

doi:10.3892/mmr.2014.2059

Inhibition of HepG2 cell proliferation by ursolic acid and polysaccharides via the downregulation of cyclooxygenase-2

Authors:
- Ling Liu
- Jingkai Zhang
- Meiling Li
- Xiaohong Zhang
- Jinlu Zhang
- Zhenjing Li
- Likui Wang
- Jihui Wu
- Cheng Luo
View Affiliations

Affiliations: Key Laboratory of Food Nutrition and Safety, Tianjin University of Science and Technology, Ministry of Education, School of Food Engineering and Biotechnology, Tianjin University of Science and Technology, Tianjin 300457, P.R. China, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, P.R. China, School of Life Science, Chinese University of Science and Technology, Hefei, Anhui 230026, P.R. China
Published online on: March 17, 2014 https://doi.org/10.3892/mmr.2014.2059
Pages: 2505-2511

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Cyclooxygenase (COX)-2, a multi-functional molecule, is overexpressed in hepatocellular carcinomas. In order to understand cell proliferation and its association with COX-2 in HepG2 cells in the presence of ursolic acid (UA), viili exopolysaccharides (VEPS) and Astragalus polysaccharides (APS), the cell proliferation, superoxide dismutase (SOD) and metabolic malondialdehyde (MDA) of fatty acids, COX-2, prostaglandin E2 (PGE2), as well as apoptotic morphology and rate were investigated. The results revealed that the activities of SOD, COX-2 and PGE2 were reduced, MDA was markedly decreased, apoptotic blebs were induced, and HepG2 cells were accumulated in the G1 and sub G1/apoptotic phases in test groups. The results indicated that UA, VEPS, APS and any combination of these possess anticancer properties, particularly by downregulating COX-2 expression, which may have increased internal oxidation and triggered apoptosis together with a change in internal antioxidant response elements, leading to a reduction in cell proliferation.

View Figures

View References

1	Lodato F, Mazzella G, Festi D, Azzaroli F, Colecchia A and Roda E: Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations. World J Gastroenterol. 12:7239–7249. 2006.
2	El-Serag HB: Epidemiology of hepatocellular carcinoma. Clin Liver Dis. 5:87–107. 2001. View Article : Google Scholar
3	Goodgame B, Shaheen NJ, Galanko J and El-Serag HB: The risk of end stage liver disease and hepatocellular carcinoma among persons infected with hepatitis C virus: publication bias? Am J Gastroenterol. 98:2535–2342. 2003. View Article : Google Scholar : PubMed/NCBI
4	Simonetti RG, Cammà C, Fiorello F, Politi F, D’Amico G and Pagliaro L: Hepatocellular carcinoma: a worldwide problem and the major risk factors. Dig Dis Sci. 36:962–972. 1991. View Article : Google Scholar : PubMed/NCBI
5	Liu J: Oleanolic acid and ursolic acid: research perspectives. J Ethnopharmacol. 100:92–94. 2005. View Article : Google Scholar : PubMed/NCBI
6	Aggarwal BB and Shishodia S: Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol. 71:1397–1421. 2006. View Article : Google Scholar : PubMed/NCBI
7	Hsu YL, Kuo PL and Lin CC: Proliferative inhibition, cell-cycle dysregulation, and induction of apoptosis by ursolic acid in human non-small cell lung cancer A549 cells. Life Sci. 75:2303–2316. 2004. View Article : Google Scholar : PubMed/NCBI
8	Choi BM, Park R, Pae HO, et al: Cyclic adenosine monophosphate inhibits ursolic acid-induced apoptosis via activation of protein kinase A in human leukaemic HL-60 cells. Pharmacol Toxicol. 86:53–58. 2000. View Article : Google Scholar : PubMed/NCBI
9	Choi YH, Baek JH, Yoo MA, et al: Induction of apoptosis by ursolic acid through activation of caspases and down-regulation of c-IAPs in human prostate epithelial cells. Int J Oncol. 17:565–571. 2000.PubMed/NCBI
10	Huang MT, Ho CT, Wang ZY, et al: Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid. Cancer Res. 54:701–708. 1994.PubMed/NCBI
11	Nishino H, Nishino A, Takayasu J, et al: Inhibition of the tumor-promoting action of 12-O-tetradecanoylphorbol-13-acetate by some oleanane-type triterpenoid compounds. Cancer Res. 48:5210–5215. 1988.PubMed/NCBI
12	Cha HJ, Bae SK, Lee HY, et al: Anti-invasive activity of ursolic acid correlates with the reduced expression of matrix metalloproteinase-9 (MMP-9) in HT1080 human fibrosarcoma cells. Cancer Res. 56:2281–2284. 1996.PubMed/NCBI
{ label needed for ref[@id='b13-mmr-09-06-2505'] }	[13] Saxelin ML, Nurmiaho-Lassila EL, Meriläinen VT and Forsén RI: Ultrastructure and host specificty of bacteriophages of Streptococcus cremoris, Streptococcus lactis subsp diacetylactis, and Leuconostoc cremoris from Finnish fermented milk ‘viili’. Appl Environ Microbiol. 52:771–777. 1986.PubMed/NCBI
14	Liu L, Wu J, Zhang J, et al: A compatibility assay of ursolic acid and foodborne microbial exopolysaccharides by antioxidant power and anti-proliferative properties in hepatocarcinoma cells. J Food Agric Environ. 10:111–114. 2012.
15	Kitazawa H, Yamaguchi T and Itoh T: B-cell mitogenic activity of slime products produced from slime-forming, encapsulated Lactococcus lactis ssp cremoris. J Dairy Sci. 75:2946–2951. 1992. View Article : Google Scholar : PubMed/NCBI
16	Shao BM, Xu W, Dai H, et al: A study on the immune receptors for polysaccharides from the roots of Astragalus membranaceus, a Chinese medicinal herb. Biochem Biophys Res Commun. 320:1103–1111. 2004. View Article : Google Scholar : PubMed/NCBI
17	Ross R: Atherosclerosis - an inflammatory disease. N Eng J Med. 340:115–126. 1999. View Article : Google Scholar
18	Akhtar M, Cheng Y, Magno RM, et al: Promoter methylation regulates Helicobacter pylori-stimulated cyclooxygenase-2 expression in gastric epithelial cells. Cancer Res. 61:2399–2403. 2001.
19	Kim H, Lim JW and Kim KH: Helicobacter pylori-induced expression of interleukin-8 and cyclooxygenase-2 in AGS gastric epithelial cells: mediation by NF-kappaB. Scand J Gastroenterol. 36:706–716. 2001.
20	Shariat SF, Kim JH, Ayala GE, et al: Cyclooxygenase-2 is highly expressed in carcinoma in situ and T1 transitional cell carcinoma of the bladder. J Urol. 169:938–942. 2003. View Article : Google Scholar : PubMed/NCBI
21	Leng J, Han C, Demetris AJ, et al: Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis. Hepatology. 38:756–768. 2003. View Article : Google Scholar : PubMed/NCBI
22	Baek JY, Hur W, Wang JS, et al: Selective COX-2 inhibitor, NS-398, suppresses cellular proliferation in human hepatocellular carcinoma cell lines via cell cycle arrest. World J Gastroenterol. 13:1175–1181. 2007. View Article : Google Scholar : PubMed/NCBI
23	Mantovani A, Allavena P, Sica A and Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008. View Article : Google Scholar
24	Coussens LM and Werb Z: Inflammation and cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI
25	Oztürk HS, Karayvaz M, Kaçmaz M, et al: Activities of the enzymes participating in purine and free-radical metabolism in cancerous human colorectal tissues. Cancer Biochem Biophs. 16:157–168. 1998.PubMed/NCBI
26	Eapen CE, Madesh M, Balasubramanian KA, et al: Mucosal mitochondirial function and antioxidation defences in patients with gastric carcinoma. Scand J Gastroenterol. 33:975–981. 1998. View Article : Google Scholar : PubMed/NCBI
27	Luo C, Urgard E, Vooder T and Metspalu A: The role of COX-2 and Nrf2/ARE in anti-inflammation and antioxidative stress: Ageing and anti-ageing. Med Hypotheses. 77:174–178. 2011. View Article : Google Scholar : PubMed/NCBI
28	Chen C: COX-2’s new role in inflammation. Nat Chem Biol. 6:401–402. 2010.
29	Groeger AL, Cipollina C, Cole MP, Woodcock SR, et al: Cyclooxygenase-2 generates anti-inflammatory mediators from omega-3 fatty acids. Nat Chem Biol. 6:433–441. 2010. View Article : Google Scholar : PubMed/NCBI
30	Kerr JF, Winterford CM and Harmon BV: Apoptosis. Its significance in cancer and cancer therapy. Cancer. 73:2013–2026. 1994. View Article : Google Scholar : PubMed/NCBI
31	Elstein KH and Zucker RM: Comparison of cellular and nuclear flow-cytometric techniques for discriminating apoptotic subpopulations. Exp Cell Res. 211:322–331. 1994. View Article : Google Scholar : PubMed/NCBI
32	Lebeer S, Claes IJ, Verhoeven TL, et al: Exopolysaccharides of Lactobacillus rhamnosus GG form a protective shield against innateimmune factors in the intestine. Microb Biotechnol. 4:368–374. 2011.
33	Goodman MT, Wu AH, Tung KH, et al: Association of dairy products, lactose, and calcium with the risk of ovarian cancer. Am J Epidemiol. 156:148–157. 2002. View Article : Google Scholar : PubMed/NCBI